The risk of cancer among persons with a history of injecting drug use in Sweden – a cohort study based on participants in a needle exchange program

References

• Serraino D, Boschini A, Carrieri P, Pradier C, Dorrucci M, Maso LD, . Cancer risk among men with, or at risk of, HIV infection in southern Europe. AIDS 2000;14:553–9.
   PubMed Web of Science ®Google Scholar
• Lehman EM, Wilson ML. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: A systematic review and meta-analysis. Int J Cancer 2009;124:690–7.
   PubMed Web of Science ®Google Scholar
• Strauss R, Torner A, Duberg A-S, Hultcrantz R, Ekdahl K. Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden – a low endemic country. J Viral Hepat 2008;15:531–7.
   PubMed Web of Science ®Google Scholar
• Campbell JV, Hagan H, Latka MH, Garfein RS, Golub ET, Coady MH, . High prevalence of alcohol use among hepatitis C virus antibody positive injection drug users in three US cities. Drug Alcohol Depend 2006;81:259–65.
   PubMed Web of Science ®Google Scholar
• Trump DL, Johnson CS, Giovannucci E. The epidemiology of vitamin D and cancer risk. In: Vitamin D and cancer. New York: Springer; 2011. pp. 73–97.
   Google Scholar
• Dal Maso L, Franceschi S, Polesel J, Braga C, Piselli P, Crocetti E, . Risk of cancer in persons with AIDS in Italy, 1985–1998. Br J Cancer 2003;89:94–100.
   PubMed Web of Science ®Google Scholar
• Jonsson AK, Holmgren P, Druid H, Ahlner J. Cause of death and drug use pattern in deceased drug addicts in Sweden, 2002–2003. Forensic Sci Int 2007;169:101–7.
   PubMed Web of Science ®Google Scholar
• Bargagli AM, Hickman M, Davoli M, Perucci CA, Schifano P, Buster M, . Drug-related mortality and its impact on adult mortality in eight European countries. Eur J Public Health 2006;16:198–202.
   PubMed Web of Science ®Google Scholar
• Miller C, Kerr T, Strathdee S, Li K, Wood E. Factors associated with premature mortality among young injection drug users in Vancouver. Harm Reduct J 2007;4:1.
   PubMedGoogle Scholar
• McKnight B, McKnight I, Kerr T, Li K, Montaner J, Wood E. Prevalence and correlates of cervical cancer screening among injection drug users. J Obstet Gynaeocol Can 2006; 28: 695–9.
   PubMedGoogle Scholar
• Olsson B, Adamsson-Wahren C, Byqvist S. Det tunga narkotikamissbrukets omfattning i Sverige 1998 (MAX-projektet, delrapport 3 Nr 61) (The extent of heavy drug abuse in Sweden 1998 [MAX-project, report 3 Nr 61]). Stockholm: Centralförbundet för alkohol- och narkotikaupplysning (CAN); 2001.
   Google Scholar
• Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register – a sample survey for year 1998. Acta Oncol 2009;48:27–33.
   PubMed Web of Science ®Google Scholar
• Lidell FDK. Simple exact analysis of the standardised mortality ratio. J Epidemiol Community Health 1984;38:85–8.
   PubMed Web of Science ®Google Scholar
• Månsson A-S, Moestrup T, Nordenfelt E. Continued transmission of Hepatitis B and C viruses, but no transmission of human immunodeficiency virus among intravenous drug users participating in a syringe/needle exchange program. Scand J Infect Dis 2000;32:253–8.
   PubMed Web of Science ®Google Scholar
• Alanko Blomé M, Björkman P, Flamholc L, Jacobsson H, Molnegren V, Widell A. Minimal transmission of HIV despite persistently high transmission of hepatitis C virus in a Swedish needle exchange program. J Viral Hepat Epub 2010.
   Google Scholar
• Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, . Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992–2003. Ann Intern Med 2008;148: 728–36.
   PubMed Web of Science ®Google Scholar
• Widell A, Verbaan H, Wejstål R, Kaczynski J, Kidd-Ljunggren K, Wallerstedt S. Hepatocellular carcinoma in Sweden: Its association with viral hepatitis, especially with Hepatitis C viral genotypes. Scand J Infect Dis 2000;32:147–52.
   PubMedGoogle Scholar
• Kanwal F, Hoang T, Kramer JR, Asch SM, Goetz MB, Zeringue A, . Increasing prevalence of HCC and cirrhosis in patients with chronic Hepatitis C virus infection. Gastroenterology 2011;140:1182–8.
   PubMed Web of Science ®Google Scholar
• Duberg A-S, Nordstrom M, Torner A, Reichard O, Strauss R, Janzon R, . Non-Hodgkin’s lymphoma and other nonhepatic malignancies in Swedish patients with hepatitis C virus infection. Hepatology (Baltimore, Md.), 2005;41:652–9.
   PubMed Web of Science ®Google Scholar
• Aldington S, Harwood M, Cox B, Weatherall M, Beckert L, Hansell A, . Cannabis use and risk of lung cancer: A case-control study. Eur Respir J 2008;31:280–6.
   PubMed Web of Science ®Google Scholar
• Bosetti C, Gallus S, Franceschi S, Levi F, Bertuzzi M, Negri E, . Cancer of the larynx in non-smoking alcohol drinkers and in non-drinking tobacco smokers. Br J Cancer 2002;87:516–8.
   PubMed Web of Science ®Google Scholar
• Kabat GC. Aspects of the epidemiology of lung cancer in smokers and nonsmokers in the United States. Lung Cancer 1996;15:1–20.
   PubMed Web of Science ®Google Scholar
• Rodriguez T, Altieri A, Chatenoud L, Gallus S, Bosetti C, Negri E, . Risk factors for oral and pharyngeal cancer in young adults. Oral Oncol 2004;40:207–13.
   PubMed Web of Science ®Google Scholar
• McLaughlin-Drubin ME, Munger K. Viruses associated with human cancer. Biochimica et Biophysica Acta (BBA) – Molecular Basis of Disease 2008;1782:127–50.
   PubMed Web of Science ®Google Scholar
• Syrjanen S. Human papillomavirus (HPV) in head and neck cancer. J Clin Virol 2005;32(Suppl 1):S59–66.
   Google Scholar